Skip to main content

Sabra Health Care REIT, Inc.

corporate_fare Company Profile

Sabra Health Care REIT, Inc.

SBRA·NASDAQ·Real Estate & Construction·CIK 0001492298

The company operates as a self-administered, self-managed real estate investment trust (REIT) that, through its subsidiaries, owns and invests in real estate serving the healthcare industry. Its primary business involves acquiring, financing, and owning real estate property leased to third-party tenants in the healthcare sector. The company primarily generates revenues by leasing properties to tenants and owning properties operated by third-party property managers across the United States and Canada. Its investment portfolio mainly consists of skilled nursing/transitional care facilities, senior housing communities (Senior Housing - Leased), behavioral health facilities, and specialty hospitals and other facilities, all leased to third-party operators. The portfolio also includes senior housing communities operated by third-party property managers under property management agreements (Senior Housing - Managed), investments in joint ventures, loans receivable, and preferred equity investments. The company aims to grow and diversify its investment portfolio by tenant, facility type, and geography within the healthcare sector. This is primarily achieved by making direct or indirect investments in healthcare real estate, including developing purpose-built healthcare facilities with select developers. The company also intends to diversify its portfolio through select asset sales and other arrangements with tenants. It elected to be treated as a REIT with the filing of its U.S. federal income tax return for the taxable year beginning January 1, 2011.

Sabra Health Care REIT, Inc. (NASDAQ:SBRA) is a publicly traded company in the Real Estate & Construction sector. Wiseek has independently scored 7 items for SBRA at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-08-03, rated 8/10. Across its 7 most recent items scored 7 or higher, the top rating is 8/10, with 4 rated 8 or above. Recent SEC coverage for SBRA spans 8-K, 10-Q, 10-K.

Recent high-impact activity:

  • Sabra Q2 Normalized FFO Hits $0.38, Closes $274M in Deals, Reiterates Raised 2026 Guidance
  • Sabra Raises 2026 AFFO Guidance to $1.58-$1.60, Up from Prior View
  • Sabra Lifts 2026 Outlook as Tenant Overhaul and Debt Settlement Reshape Portfolio
  • Sabra Health Care REIT Details $277M YTD Acquisitions, $410M Pipeline, and $79M Dispositions
  • Sabra Health Care REIT Reports Strong Q1 Revenue Growth, Increased FFO, and Strategic Portfolio Activity

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$774.63M
Net Income
$155.61M
Diluted EPS
$0.64
Op. Cash Flow
$348.61M
Free Cash Flow
-$104.32M
Cash & Equivalents
$71.54M
Total Debt
$2.53B
Debt / Equity
0.90×
Net Margin
20.1%
Shares Outstanding
251.7M sh
Source: 10-K · filed 2026-02-12 · accession 0001492298-26-000008

Short Interest & Short Volume

9.12 days to cover

FINRA reported short interest of 21,015,330 shares in SBRA as of the September 15, 2026 settlement, a 8.5% increase from the prior period — about 9.1 days to cover at its recent average daily volume. On October 2, 2026, 69.2% of SBRA volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)21,015,330 shares as of September 15, 2026
Change vs prior period▲ 8.5%
Days to cover9.12 at avg daily volume of 2,305,099
Daily short volume (FINRA facilities)69.2% of 898,765 shares on October 2, 2026
5-day average short volume57.7%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Dilution Risk

Low risk

Filing-implied dilution signals for SBRA, detected from its recent SEC filings.

ATM program

Significant Year-to-Date Acquisitions · Robust Investment Pipeline

A filing-implied signal, not a realized share count. How Wiseek tracks dilution →

Browse all tickers starting with S →
$19.13 -0.03% today
52-week range · as of 2026-07-21 $17.16 – $21.28
Market cap
$4.89B
Volume
3.1M (1.3× avg)
3-mo avg 2.3M
Live data · 2026-10-05 05:11 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed SBRA - Latest Insights

SBRA
Aug 03, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $20.61
Real-time Price: $19.13 info
Change: -$1.48 (-7%) info
Market Cap: $4.895B info
SBRA
Jul 21, 2026, 9:12 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $19.84
Real-time Price: $19.13 info
Change: -$0.710 (-4%) info
Market Cap: $4.895B info
SBRA
Jul 21, 2026, 9:05 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $20.00
Real-time Price: $19.13 info
Change: -$0.870 (-4%) info
Market Cap: $4.895B info
SBRA
May 28, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $20.28
Real-time Price: $19.13 info
Change: -$1.15 (-6%) info
Market Cap: $4.895B info
SBRA
Apr 29, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $20.35
Real-time Price: $19.13 info
Change: -$1.22 (-6%) info
Market Cap: $4.895B info
SBRA
Feb 12, 2026, 4:07 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $19.60
Real-time Price: $19.13 info
Change: -$0.470 (-2%) info
Market Cap: $4.895B info
SBRA
Feb 12, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $19.60
Real-time Price: $19.13 info
Change: -$0.470 (-2%) info
Market Cap: $4.895B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets